The complex IV subunit Co1 and the biogenesis marker Pgc1α were upregulated, which is in line with the adaptive increase in mitochondrial capacity seen in more early-stage MASLD24 (Fig. S6) – as ALT levels, steatosis, and fibrosis severity were lower than in the maternal WD model. This evidence concerns the gene PPARGC1A and steatosis.